4.6 Article

Comparison of eMAG™ versus NucliSENS® EasyMAG® performance on clinical specimens

Journal

JOURNAL OF CLINICAL VIROLOGY
Volume 88, Issue -, Pages 52-57

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jcv.2017.01.004

Keywords

eMAG (TM); easyMAG (R); Nucleic acid extraction; Evaluation; Clinical specimens

Categories

Ask authors/readers for more resources

Background: eMAG (TM) (bioMerieux) is a new nucleic acid extraction platform based on magnetic silica technology, like its predecessor, NucliSENS (R) easyMAG (R) (bioMerieux). Using the same reagents and disposables, eMAG (TM) adds further automation, allowing simultaneous extraction of 48 samples directly from primary tubes, and distribution of nucleic acid extracts on PCR strips or in tubes at the end of the extraction process. Objective: To compare the performance of eMAG (TM) and easyMAG (R) on various clinical specimens. Study design: Respiratory (n = 199), whole blood (n=50), plasma (n = 25) and urine (n = 25) specimens were extracted in parallel on both platforms. Both qualitative (respiratory virus, cell control, CMV, EBV, HHV6 and BKV detection) and quantitative (respiratory virus and cell control cycle thresolds, and CMV, EBV, HHV6 and BKV viral loads) results were compared. Results: Detection of qualitative targets showed good agreement, ranging from 84.6% for whole blood to 95.9% for respiratory specimens. Correlations between quantitative results were good, with R-2 ranging from 0.802 to 0.995. Quantitative results showed average overall differences below 0.10 log(10) copies/mL between eMAG (TM) and easyMAG (R). Conclusions: The two platforms showed comparable performance on the types of clinical specimen tested. With higher automation and throughput than easyMAG (R), the eMAG (TM) platform is likely to be advantageous for laboratories performing a large number of molecular analyses. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021

Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, Alessio Andronico, Sonia Burrel, Sylvie Behillil, Claire Sauvages, Antonin Bal, Florence Morfin, Sylvie Van der Werf, Laurence Josset, Francois Blanquart, Bruno Coignard, Simon Cauchemez, Bruno Lina

Summary: The emergence of the SARS-CoV-2 variant 201/501Y.V1 in France is concerning due to its increased transmissibility. Recent data shows that this variant is 52-69% more transmissible compared to previously circulating lineages, with a prevalence of 6.9% in the Paris region.

EUROSURVEILLANCE (2021)

Letter Otorhinolaryngology

Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial

Jeremy Guenezan, Magali Garcia, Deidre Strasters, Clement Jousselin, Nicolas Leveque, Denis Frasca, Olivier Mimoz

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2021)

Article Infectious Diseases

Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trial

Thierry Prazuck, Renaud Verdon, Gwenael Le Moal, Faiza Ajana, Louis Bernard, Simon Sunder, Mariam Roncato-Saberan, Diane Ponscarme, Manuel Etienne, Jean-Paul Viard, Thierry Pasdeloup, Iuliana Darasteanu, Gilles Pialoux, Arnaud de la Blanchardiere, Veronique Avettand-Fenoel, Jean-Jacques Parienti, Laurent Hocqueloux

Summary: The study compared the maintenance effect of tenofovir disoproxil fumarate/emtricitabine with traditional triple therapy in people living with HIV, showing similar viral suppression rates at 48 weeks but a higher incidence of virological failures in the tenofovir disoproxil fumarate/emtricitabine group.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Letter Virology

Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital

Florent Hubert, Celine Chessa, Agnes Beby-Defaux, Anne Bourgoin, Laurence Boinot, Ursula Noury, Andy Lariviere, Mohammed Benlaassri, Magali Garcia, Nicolas Leveque

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Virology

The Antiviral Activities of Poly-ADP-Ribose Polymerases

Mathilde Malgras, Magali Garcia, Clement Jousselin, Charles Bodet, Nicolas Leveque

Summary: PARPs are enzymes responsible for a reversible post-translational modification involved in various cellular processes, including DNA damage repair, chromatin remodeling, translation regulation, and cell death. Recent studies have highlighted the role of PARPs in host defense against viruses, as well as strategies developed by viruses to evade their actions.

VIRUSES-BASEL (2021)

Article Infectious Diseases

Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease

Amine Benadji, Xavier Duval, Kostas Danis, Bruno Hoen, Bernard Page, Guillaume Beraud, Veronique Vernet-Garnier, Christophe Strady, Nathalie Brieu, Laurence Maulin, Carine Roy, Marie-Cecile Pioy, Jacques Gaillat, Emmanuelle Varon, Sarah Tubiana

Summary: This study found that both host factors and pneumococcal serotypes have an impact on 30-day mortality in invasive pneumococcal disease patients, emphasizing the need for a targeted vaccination strategy for high-risk populations.

INFECTION (2022)

Article Medicine, Research & Experimental

One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study

Xavier Duval, Muhamed-Kheir Taha, Isabelle Lamaury, Lelia Escaut, Isabelle Gueit, Pauline Manchon, Sarah Tubiana, Bruno Hoen

Summary: Although most patients with meningococcal meningitis survive, they face substantial long-term burden, emphasizing the importance of prolonged follow-up and preventive strategies, including vaccination.

ADVANCES IN THERAPY (2022)

Article Infectious Diseases

Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis

Souade Akroum, Sarah Tubiana, Thomas de Broucker, Nathalie Dournon, Emmanuelle Varon, Marie Cecile Ploy, Bruno Mourvillier, Eric Oziol, Flore Lacassin, Henri Laurichesse, Bruno Hoen, Xavier Duval, Charles Burdet

Summary: This study investigated the prevalence and determinants of neuro-functional disability 12 months after community-acquired bacterial meningitis (CABM) in adult patients. The findings showed that approximately 29.9% of the 281 patients exhibited neuro-functional disability at 12 months, with 28.1% having functional disability and 18.1% having physical disability. Factors associated with neuro-functional disability included pneumococcal meningitis, presence of physical disability at hospital discharge, and presence of behavioral disorders at hospital discharge.

INFECTION (2022)

Letter Infectious Diseases

Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)

Guillaume Martin-Blondel, Anne-Genevieve Marcelin, Cathia Soulie, Sofia Kaisaridi, Clovis Lusivika-Nzinga, Celine Dorival, Laura Nailler, Anais Boston, Clea Melenotte, Geraldine Gaube, Christophe Choquet, Roland Liblau, Fabrice Carrat, Youri Yordanov

JOURNAL OF INFECTION (2022)

Article Infectious Diseases

Combined Bacterial Meningitis and Infective Endocarditis: When Should We Search for the Other When Either One is Diagnosed?

Guillaume Beraud, Sarah Tubiana, Marie-Line Erpelding, Vincent Le Moing, Catherine Chirouze, Isabelle Gorenne, Pauline Manchon, Pierre Tattevin, Veronique Vernet, Emmanuelle Varon, Bruno Hoen, Xavier Duval

Summary: The study described patients with coexisting infective endocarditis and bacterial meningitis, finding that the main presentation was meningitis, with most common pathogens being Streptococcus pneumoniae and Staphylococcus aureus. The results of this study are important for the identification and treatment of patients with dual infections.

INFECTIOUS DISEASES AND THERAPY (2022)

Article Virology

Antiviral Effect of hBD-3 and LL-37 during Human Primary Keratinocyte Infection with West Nile Virus

Celine Chessa, Charles Bodet, Clement Jousselin, Andy Lariviere, Alexia Damour, Julien Garnier, Nicolas Leveque, Magali Garcia

Summary: LL-37 can directly inhibit West Nile virus (WNV), while hBD-3 does not have an inhibitory effect on WNV replication. Both peptides have immunomodulatory properties in WNV-infected keratinocytes.

VIRUSES-BASEL (2022)

Article Immunology

Efficacy and Safety of Doravirine-Based Regimens in Real Life: A Prospective Monocentric French Study

Magali Garcia, Jean Philippe Martellosio, Valentin Giraud, Guillaume Beraud, Melanie Catroux, France Roblot, Gwenael Le Moal

Summary: Doravirine (DOR) has shown good efficacy and safety in adult naive or treated patients, making it a safe and relevant strategy to avoid drug interactions and drugs with poor metabolic tolerance.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2022)

Article Immunology

Pooling Rectal, Pharyngeal, and Urine Samples to Detect Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium Using Multiplex Polymerase Chain Reaction Is as Effective as Single-Site Testing for Men Who Have Sex With Men

Thierry Prazuck, Philippe Lanotte, Gwenael Le Moal, Laurent Hocqueloux, Simon Sunder, Melanie Catroux, Magali Garcia, Pascale Perfezou, Guillaume Gras, Chloe Plouzeau, Nicolas Leveque, Agnes Beby-Defaux

Summary: Pooling samples from MSM to detect CT, NG, and MG is as sensitive as individual-site testing for these 3 pathogens. Missed infections only occurred for samples with a low bacterial load, which may have a low impact on further transmission.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Immunology

Severe Bacterial Non-AIDS Infections in Persons With Human Immunodeficiency Virus: The Epidemiology and Evolution of Antibiotic Resistance Over an 18-Year Period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine Cohort

Peggy Blanc, Fabrice Bonnet, Olivier Leleux, Adelaide Perrier, Emilie Bessede, Sabine Pereyre, Charles Cazanave, Didier Neau, Marc-Olivier Vareil, Estibaliz Lazaro, Pierre Duffau, Aurelie Saunier, Katell Andre, Linda Wittkop, Marie-Anne Vandenhende

Summary: This large prospective cohort study examined the types of severe non-AIDS bacterial infections (SBIs) among people with HIV, as well as the bacterial documentation and antibiotic resistance patterns over an 18-year period. The study found that the proportion of Streptococcus pneumoniae infections in HIV patients decreased over time, as did resistance of Staphylococcus aureus and Streptococcus pneumoniae, while resistance of Enterobacteriaceae increased. The use of cotrimoxazole as prophylaxis was associated with an increased risk of antibiotic resistance.

CLINICAL INFECTIOUS DISEASES (2023)

Article Chemistry, Medicinal

Anti-SARS-CoV-2 Activity of Polysaccharides Extracted from Halymenia floresii and Solieria chordalis (Rhodophyta)

Clement Jousselin, Hugo Pliego-Cortes, Alexia Damour, Magali Garcia, Charles Bodet, Daniel Robledo, Nathalie Bourgougnon, Nicolas Leveque

Summary: By testing polysaccharide fractions from Halymenia floresii and Solieria chordalis, it was found that the polysaccharide fractions from Halymenia floresii have antiviral activity against SARS-CoV-2, while those from Solieria chordalis do not. This study confirms that carrageenans can be used as a first-line treatment to inhibit the infection and transmission of SARS-CoV-2.

MARINE DRUGS (2023)

No Data Available